Private Prostate Cancer Cover UK

Prostate cancer is the most common cancer in UK men (~55,100/year). Full-cover PMI funds mpMRI, targeted biopsy, PSMA-PET staging, robotic prostatectomy, external beam radiotherapy, brachytherapy, hormone therapy and next-generation drugs (abiraterone, enzalutamide). Premiums for a 55-year-old man on comprehensive + full cancer cover start from £128/month.

Prostate Cancer Cover: what the cover actually does

Around 55,100 UK men are diagnosed with prostate cancer each year (Cancer Research UK). Screening is not routine — most diagnoses follow PSA testing after symptoms or family history. Private pathways collapse the diagnostic timeline from 6–8 weeks (NHS) to 10–14 days.

A full-cover PMI policy funds: same-week urology consultation, PSA and multi-parametric MRI (mpMRI) within 10 days, MRI-guided targeted biopsy, PSMA-PET staging where clinically indicated, radical prostatectomy (increasingly robotic — da Vinci system), external beam radiotherapy (IMRT), brachytherapy, high-intensity focused ultrasound (HIFU) where appropriate, and androgen deprivation therapy (LHRH agonists, anti-androgens).

For advanced disease, full-cover policies fund next-generation hormonal therapies (abiraterone, enzalutamide, apalutamide) and chemotherapy (docetaxel, cabazitaxel). Coverage of Lu-177 PSMA radioligand therapy (a newer treatment) is emerging — always confirm before diagnosis.

Key numbers our brokers work from

• UK prostate cancer cases per year: ~55,100 (Cancer Research UK)
• 1 in 8 UK men diagnosed in lifetime: 12.5% (Prostate Cancer UK)
• Private mpMRI wait — median: 5–10 days (PHIN 2024)
• Private robotic prostatectomy self-pay cost: £16,000–£22,000 (PHIN self-pay data)
• Full private prostate cancer pathway cost: £25,000–£90,000+ (LaingBuisson)
• PMI policies covering robotic surgery: ~92% (PremierPMI advisor data)

Indicative monthly cost by scenario

Illustrative only — final premiums depend on age, postcode, excess, hospital list, underwriting and insurer terms at the time of quote.

Which insurers tend to fit best

Before you buy — broker checklist

• Confirm 'full' cancer cover — core policies cap next-gen hormonal therapies.
• Verify robotic (da Vinci) prostatectomy is funded.
• Ask if PSMA-PET staging is included (newer test — not universal).
• Check brachytherapy and HIFU are covered where clinically appropriate.
• Confirm access to specialist urology centres (Royal Marsden, HCA, Cromwell).
• Ask about hormonal therapy duration cover (may be 2–5 years).
• Verify psychological support and continence/erectile function rehabilitation are included.

PremierPMI broker desk notes

• Men over 45 with a family history of prostate cancer should buy PMI proactively — once PSA is elevated, the condition becomes pre-existing.
• Robotic prostatectomy at a leading unit (HCA, Cleveland Clinic London) delivers materially better continence and erectile function outcomes than open surgery. Always place cover that funds it.
• The Exeter Health+ is often overlooked but is our most competitive placement for men aged 55–65 with clean history.
• For active surveillance patients (low-grade disease), PMI continues to fund regular mpMRI, biopsies and PSA — a huge quality-of-life benefit.

Common questions

Does PMI cover PSA testing?

Not routinely for asymptomatic screening — this is considered preventative. Once symptoms or elevated PSA emerge and a GP refers, all diagnostic work (further PSA, mpMRI, biopsy) is fully covered on comprehensive policies.

Is robotic (da Vinci) prostatectomy covered?

Yes on almost all UK PMI policies with cancer cover — Bupa, AXA, Aviva, Vitality, Freedom and The Exeter all fund robotic surgery at HCA, Cleveland Clinic London, Nuffield and Spire.

Does PMI cover PSMA-PET scans?

Increasingly yes on full-cover policies — Bupa, AXA and Aviva fund PSMA-PET where clinically recommended for staging or biochemical recurrence. Always pre-authorise.

Are next-generation drugs like abiraterone and enzalutamide covered?

Yes on full-cover policies. Core policies may cap. Always check the drug list in the policy schedule.

How fast can I see a private urologist?

Typically 3–7 working days. mpMRI within 10 days. Targeted biopsy within 2–3 weeks. Compared to 6–8 weeks on the NHS.

Can I have active surveillance on PMI?

Yes — PMI continues to fund regular monitoring (PSA, mpMRI, biopsies) for men on active surveillance for low-risk prostate cancer.

Is brachytherapy covered?

Yes on comprehensive policies — brachytherapy is a NICE-approved option and fully funded where clinically appropriate.

What if I have a strong family history?

Family history alone is not a pre-existing condition and does not affect underwriting terms on moratorium. Buy cover before any PSA elevation.

PremierPMI is a UK private medical insurance broker specialising in whole-of-market placement across 10+ leading UK health insurers including Bupa, AXA Health, Aviva, Vitality, WPA, Freedom Health, The Exeter, General & Medical and National Friendly. FCA regulated (Tesha Family Ltd, FRN 1029667). Speak to a broker on 020 4525 0884, WhatsApp 020 8064 2273, or email contact@premierpmi.co.uk.